Peptide therapy for skin aging works on the systemic biology your serums cannot reach. Here is what the research shows and how protocols are sequenced.

SS-31 and NAD+ target aging mitochondria through two different mechanisms. Here is why combining them produces results that neither compound achieves on its own.

GHK-Cu is the most researched skin peptide available. Here is what it does, why your body produces less of it with age, and how AIRA uses it in both injectable and topical forms.

Epithalon, NAD+, GHK-Cu, MOTS-c: each one targets a different dimension of how your body ages. Here is how physicians think about combining them into a protocol designed around your biology, not someone else's.

BPC-157 is derived from a protein naturally present in the human body, and the preclinical research on its effects on tissue repair, gut health, and recovery is genuinely compelling. Here is an honest look at the science, the evidence gaps, and what physician-guided use actually looks like.

Peptide therapy works very differently depending on who is guiding it. Here is what the real process looks like at AIRA: the intake, the physician consultation, what you will notice in the first 30 to 60 days, and why ongoing oversight is what separates results from disappointment.

Viagra and Cialis work on blood flow. PT-141 works on the brain. For some men, that difference changes everything. This guide breaks down how PT-141 compares to traditional ED pills, who benefits most, and what the research actually shows.

Epitalon, GHK-Cu, and NAD+ each target aging differently — from telomeres to skin regeneration to cellular energy. This guide breaks down the science, compares the three, and helps you find the right approach for your longevity goals.

Peptide legality isn't black and white — it depends entirely on how you access them. This guide breaks down the FDA regulatory landscape, what's changed in 2026, and the clear legal pathway for peptide therapy.

Not all online peptide sources are equal. This guide breaks down how to access peptide therapy safely and legally through telehealth, what red flags to watch for, and what the process looks like when done right.

BPC-157 has generated buzz in fitness and biohacking communities—but what does the science actually say? We break down the research, limitations, safety considerations, and how AIRA approaches this peptide responsibly.

Discover how peptide therapy with AOD-9604, Tesamorelin, and CJC-1295/Ipamorelin supports fat metabolism and body composition — and how AIRA's personalized programs work.